Tonix Pharmaceuticals Holding Income Statement (2023-2025) | TNXP

Income Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 4.08M3.99M3.78M2.48M2.21M2.82M2.58M2.43M2.00M3.29M
Cost of Revenue 2.37M2.37M1.66M3.37M1.55M1.18M0.94M3.27M1.37M
Gross Profit 1.61M1.41M0.82M-1.16M1.27M1.40M1.49M-1.27M1.92M
Operating items
Research & Development 21.05M17.12M12.86M9.70M9.11M8.30M7.44M10.82M9.29M
Selling, General & Administrative 8.71M11.62M9.31M7.50M7.71M15.58M10.10M16.20M25.70M
Other Operating Expenses -34.45M-27.07M-28.65M1.66M62.32M1.55M1.18M0.94M3.27M1.37M
Operating Expenses 32.14M31.11M23.83M79.52M18.38M25.06M18.48M30.29M36.36M
Operating Income -28.15M-27.33M-21.35M-77.32M-15.55M-22.48M-16.05M-28.30M-33.07M
EBIT -28.15M-27.33M-21.35M-77.32M-15.55M-22.48M-16.05M-28.30M-33.07M
Non-operating items
Non Operating Investment Income 7.00M-0.85M
Interest & Investment Income 0.17M0.01M0.00M0.02M0.63M1.23M
Other Non Operating Income 0.17M0.01M-0.59M-0.61M-0.04M-1.49M-2.09M-1.96M-1.16M
Non Operating Income 0.17M0.01M-0.59M-0.61M-0.04M-1.49M0.39M-1.96M-1.16M
Net income details
EBT -27.98M-27.32M-21.35M-77.31M-15.84M-22.48M-16.05M-27.67M-31.84M
Profit After Tax -27.98M-27.32M-21.35M-77.31M-15.84M-22.48M-16.05M-27.67M-31.84M
Income from Continuing Operations -27.98M-27.32M-21.35M-77.31M-15.84M-22.48M-16.05M-27.67M-31.84M
Consolidated Net Income -27.98M-27.32M-21.35M-77.31M-15.84M-22.48M-16.05M-27.67M-31.84M
Income towards Parent Company -27.98M-27.32M-21.35M-77.31M-15.84M-22.48M-16.05M-27.67M-31.84M
Net Income towards Common Stockholders -27.98M-27.32M-14.94M-78.78M-14.21M-22.11M-16.83M-28.27M-32.01M
Additional items
EPS (Basic) -38.63-0.01M-535.72-0.00M-22.68289.57-2.84-3.86-3.59
EPS (Weighted Average and Diluted) -38.63-0.01M-535.72-0.00M-22.68289.57-2.84-3.86-3.59
Shares Outstanding (Weighted Average) 0.00M0.00M0.01M0.01M0.01M0.03M0.22M1.87M6.43M7.32M8.77M
Shares Outstanding (Diluted Average) 10.27M0.58M0.72M0.01M0.03M0.04M0.63M0.74M5.93M7.33M8.92M
EBITDA -28.15M-27.33M-21.35M-77.32M-15.55M-22.48M-16.05M-28.30M-33.07M
Interest Expenses 0.30M